A Prospective, Multicenter Clinical Investigation Evaluating the Safety of ABIO3419 in Treating Knee Osteoarthritis: Pilot Study
Latest Information Update: 23 Nov 2024
At a glance
- Drugs ABIO 3419 (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- Acronyms PILHAC
- Sponsors Symatese
Most Recent Events
- 19 Nov 2024 Status changed from recruiting to completed.
- 30 Oct 2023 New trial record